200 related articles for article (PubMed ID: 31920173)
1. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship.
Lim HJ; Nguyen TT; Kim NM; Park JS; Jang TS; Kim D
Biotechnol Lett; 2017 Mar; 39(3):415-421. PubMed ID: 27885509
[TBL] [Abstract][Full Text] [Related]
4. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
6. Zika Virus NS2A-Mediated Virion Assembly.
Zhang X; Xie X; Xia H; Zou J; Huang L; Popov VL; Chen X; Shi PY
mBio; 2019 Oct; 10(5):. PubMed ID: 31662457
[TBL] [Abstract][Full Text] [Related]
7. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
8. Binding recognition of substrates in NS2B/NS3 serine protease of Zika virus revealed by molecular dynamics simulations.
Nutho B; Rungrotmongkol T
J Mol Graph Model; 2019 Nov; 92():227-235. PubMed ID: 31401441
[TBL] [Abstract][Full Text] [Related]
9. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
Ren J; Lee H; Kotak A; Johnson ME
Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
[TBL] [Abstract][Full Text] [Related]
10. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
11. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Antiviral Peptides against the NS2B/NS3 Protease of Zika Virus.
Hossain MS; Shovon MTI; Hasan MR; Hakim FT; Hasan MM; Esha SA; Tasnim S; Nazir MS; Akhter F; Ali MA; Halim MA
ACS Omega; 2023 Sep; 8(38):35207-35218. PubMed ID: 37779969
[TBL] [Abstract][Full Text] [Related]
13. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
Starvaggi J; Previti S; Zappalà M; Ettari R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
[TBL] [Abstract][Full Text] [Related]
15. Boophilin D1, a Kunitz type protease inhibitor, as a source of inhibitors for the ZIKA virus NS2B-NS3 protease.
Manzato VM; Di Santo C; Torquato RJS; Coelho C; Gallo G; Hardy L; Würtele M; Tanaka AS
Biochimie; 2023 Nov; 214(Pt B):96-101. PubMed ID: 37364769
[TBL] [Abstract][Full Text] [Related]
16. The Structure of the Zika Virus Protease, NS2B/NS3
Hilgenfeld R; Lei J; Zhang L
Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
[TBL] [Abstract][Full Text] [Related]
17. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
[TBL] [Abstract][Full Text] [Related]
18. Substrate profiling of Zika virus NS2B-NS3 protease.
Gruba N; Rodriguez Martinez JI; Grzywa R; Wysocka M; Skoreński M; Burmistrz M; Łęcka M; Lesner A; Sieńczyk M; Pyrć K
FEBS Lett; 2016 Oct; 590(20):3459-3468. PubMed ID: 27714789
[TBL] [Abstract][Full Text] [Related]
19. Increased activity of unlinked Zika virus NS2B/NS3 protease compared to linked Zika virus protease.
Kuiper BD; Slater K; Spellmon N; Holcomb J; Medapureddy P; Muzzarelli KM; Yang Z; Ovadia R; Amblard F; Kovari IA; Schinazi RF; Kovari LC
Biochem Biophys Res Commun; 2017 Oct; 492(4):668-673. PubMed ID: 28342876
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
